Skip to content
verana-health-logo-inverted
  • Clinicians
    • MIPS Advisory Offerings
    • Practice Insights
    • Verana Trial Connect
    • Verana Quality Measures
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Therapeutic Area
    • Oncology
      • Acute Myeloid Leukemia
      • Bladder Cancer
      • Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Colorectal Cancer
      • Follicular Lymphoma
      • Large B-Cell Lymphoma
      • Lung Cancer
      • Marginal Zone Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndrome
      • Ovarian Cancer
      • Prostate Cancer
    • Ophthalmology
      • Anti-VEGF
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinal Vein Occlusion
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
    • Urology
      • Bladder Cancer
      • Prostate Cancer
    • Neurology
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
  • Solutions
    • Clinical Research Solutions
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Clinical Trials
      • Site Explorer
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
  • About Us
    • About
      • Evolve Registry
    • Team
    • Resources
    • Careers
    • Partners
      • Societies
      • CROs
      • Technology and Data
    • Privacy
      • Privacy Policy
      • Patient Privacy
Contact Us

Press

Verana Health CEO Named PharmaVoice 100 Winner

October 8, 2024
Read More...

How The Healthcare Industry Can Use AI In Clinical Trial Recruitment

September 30, 2024
Read More...

Verana Health Announces Launch of Qdata® BPH

September 30, 2024
Read More...

The Implications of Real-World Data Integration in Health Care and Ophthalmology

September 17, 2024
Read More...

Retina Society 2024: 12-month Outcomes of FARETINA and FARWIDE Studies

September 17, 2024
Read More...

The American Urological Association Expands Partnership with Verana Health for the AQUA Registry

September 11, 2024
Read More...

The Clinical Trials Tech Market Map

August 30, 2024
Read More...

Verana Health and HealthVerity Partner to Advance Use of Real-World Evidence in Research

July 29, 2024
Read More...

ASRS 2024: FARETINA-DME Study

July 22, 2024
Read More...

An Overview of Real-World Geographic Atrophy Data

July 9, 2024
Read More...
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 26
  • Next »
verana-health-logo-inverted

© 2026 Verana Health. All Rights Reserved.

San Francisco
New York
Knoxville
  • Privacy Policy
  • Cookie Policy
Back to Top